UGCG and autosomal dominant polycystic kidney disease: The molecular basis of GSL accumulation in ADPKD is not well understood, but the mammalian target of rapamycin pathway activation downstream of polycystin/primary ciliary dysfunction has been implicated, resulting in increased GCS activity and de novo ceramide synthesis.4